about
HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA PanelEthics and policy issues for stem cell research and pulmonary medicine.Patients' attitudes toward the donation of biological materials for the derivation of induced pluripotent stem cellsA Clinician's Guide to Privacy and Communication in the ICU.Marketing of unproven stem cell-based interventions: A call to action.Balancing digital information-sharing and patient privacy when engaging families in the intensive care unit.Ethics and hepatitis B cure research.Addressing ethical challenges in HIV prevention research with people who inject drugs.Ethics in the use of extracorporeal cardiopulmonary resuscitation in adults.Bringing science and advocacy together to address health needs of people who inject drugs.Worst case bioethics: Death, disaster, and public health.Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.Perceptions, motivations, and concerns about living organ donation among people living with HIVNew ISSCR guidelines: clinical translation of stem cell researchA scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy studyDevelopment and implementation of participant safety plans for international research with stigmatised populationsChallenges in the Ethical Review of Research Involving Complementary and Integrative MedicineBiometrics and public health surveillance in criminalised and key populations: policy, ethics, and human rights considerationsRegional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): a baseline analysisSafety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trialTackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session ReportEthical Issues and Recommendations in Grateful Patient Fundraising and PhilanthropyEthics and Regulatory Barriers to Research in Emergency SettingsNavigating the Ethical Boundaries of Grateful Patient FundraisingEmerging stem cell ethicsEditors' Introduction to the Special Section on Ethics, Policy, and Autologous Cellular TherapiesEthical Considerations Related to Impaired Driving After Orthopaedic InjuriesImplications of universal screening for HIV infectionIndia's new policy to protect research participantsClimate of Respect Evaluation in ICUs: Development of an Instrument (ICU-CORE)Willingness to Donate Organs Among People Living With HIVDolutegravir monotherapy: when should clinical practice be clinical research?Experimental Philosophical BioethicsEthics of HIV and hepatitis B cure researchInformed Consent for Stem Cell-Based Interventions-ReplyPreventive Misconception and Risk Behaviors in a Multinational HIV Prevention TrialThe significance and expectations of HIV cure research among people living with HIV in AustraliaReported Participation Benefits in International HIV Prevention Research with People Who Inject DrugsParticipant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366Patient's Perspectives of Experimental HCV-Positive to HCV-Negative Renal Transplantation: Report from a Single Site
P50
Q28244216-0702CA8C-F0E4-4D7C-A03E-2688985CABAAQ35190284-94676321-2DBE-405A-B06C-1C6DB9300106Q36523529-55A8117F-9765-457E-851E-688BCBD31FEEQ39030463-F714EF06-209B-4512-81CE-3DADD6187199Q39416083-AFB714A7-67F1-4789-951D-9091A308614AQ39914741-C70602ED-5B84-432F-9AF6-86E5304CE8F3Q40449724-80CF9372-2127-4EE5-B474-52D6BF75BC83Q40699304-4730B40B-715B-430E-A6B1-D1135814A249Q40726152-9EE44FAB-9023-48F6-AE90-0B4E9C13013CQ46297697-AF1F66FE-8AD2-4E60-BB3E-7AC0F53A7259Q46646389-2C715917-DE83-46E9-9AF1-B3BA89F7F9EDQ54261696-4709BC4A-6678-430C-BAE9-3CD462F18E9FQ56550658-C8FE598A-090E-4C12-9F70-9F553CE12D56Q56765987-104660D9-DC1B-477D-B9BC-567F32BD47A7Q57165201-1EA628ED-8CDD-4E4A-9E97-DA2F1E8A7996Q57173039-2D952D00-65E2-44E9-B8F3-B12777B4EF41Q57219873-BB48F1F4-2A51-41E8-9336-E9ECC44CFF1EQ57297558-29B3F297-4DB0-4C52-A2B5-23B5530003B8Q57819560-9D05B4D5-CE9E-4DC9-89B1-522DFB4E3B2BQ58587972-9659DA2E-A2B4-405A-9F3B-366754EC6E40Q58635037-5D34424B-62C0-4E5C-881B-3E50EECBFC0FQ58656886-430C18DD-0C61-4E44-84FD-58A13C286DF9Q58656926-D166EDB0-703D-4161-96D3-EE06BBF374DDQ58657053-845BB7F1-E126-43F5-8B81-4C426A1C1C7DQ58657445-27FE4427-7C96-44AD-A0CE-63680E58C4E7Q58658079-6D6290AB-1E5C-4B4F-855C-B55A2BDEFF00Q58659442-94AA4033-17A0-4696-AF76-7C180A32AA06Q86747264-27B0B5B4-34C4-4CDC-B727-0A184A1BEBB7Q87175880-299FD3F8-6558-4E41-9A92-22B8831EF6EFQ87894772-F6C3C668-25B5-438F-B9BF-E8826556F072Q88753315-21F388F6-CB46-4E52-83AF-864FE4BBB3AAQ88985340-3E95EA51-9168-430D-92CC-AE2E33BAEBE8Q89874121-A99B1B84-E0CF-453B-AF4E-A4C3CFA2B519Q89894380-4CEA5FDF-F2E0-476E-B916-7203E35DB16BQ89991884-D66BA91F-B5F9-47D6-8C70-AAADFDE8D461Q90013729-20FF947D-FAB3-4D3E-8E80-065E29E2A64AQ90039041-A932EE11-81A2-47F3-9D6C-B14DE8CB1C61Q90199251-B4F4A822-D601-4FEB-81C0-B536091C1D2BQ90241137-345737A9-C3DE-4757-9ECD-E1F3833CB63BQ90743981-545BD118-7C13-44C0-8E54-2A7200C52E7E
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Jeremy Sugarman
@en
Jeremy Sugarman
@nl
type
label
Jeremy Sugarman
@en
Jeremy Sugarman
@nl
prefLabel
Jeremy Sugarman
@en
Jeremy Sugarman
@nl
P31
P496
0000-0001-7022-8332